Patent 10918691 was granted and assigned to Ra Pharmaceuticals on February, 2021 by the United States Patent and Trademark Office.
The present invention provides polypeptide modulators of complement activity, including cyclic polypeptide modulators. Also provided are methods of utilizing such modulators as therapeutics.